- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 29.05. | ASCO: BMS hails "compelling" phase 3 celmod readout | ||
| 29.05. | Pharmacy First prescribing expanded to ease GP pressure | ||
| 29.05. | Review advises against broad NHS prostate cancer screening | ||
| 29.05. | WHO names three 'priority' Ebola drugs for trials | ||
| 29.05. | Ahead of ASCO data drop, AZ gets key Imfinzi approval | ||
| 29.05. | Innovent in line for $10.5bn in Pfizer cancer alliance | ||
| 28.05. | France 'first EU country to cover obesity drugs' | ||
| 28.05. | GSK hails 'unprecedented' cure rates with hep B drug | ||
| 28.05. | EpiWatch app detects major seizures with few false alarms | ||
| 28.05. | November date set for FDA decision on Sanofi's Gaucher drug | ||
| 28.05. | AbbVie's Immunogen buy delivers rare cancer drug approval | ||
| 27.05. | Zuckerberg, Chan's Biohub launches protein 'world model' | ||
| 27.05. | FDA delays verdict on AZ breast cancer drug | ||
| 27.05. | Heart drug developer Kardigan files IPO | ||
| 27.05. | Roche launches liver disease algorithm panel | ||
| 27.05. | Philanthropic drive puts $140m behind strep A vaccine | ||
| 26.05. | Lilly gets back in infectious disease, via three M&A deals | ||
| 26.05. | Arthrosi drug trial in gout delivers for new owner Sobi | ||
| 26.05. | Datroway is first TROP2 drug for frontline breast cancer | ||
| 26.05. | Newel Health, Gerresheimer team up to help pharma embrace digital | ||
| 26.05. | Newel, Gerresheimer team up to help pharma embrace digital | ||
| 25.05. | Gilead claims first FDA nod for a hepatitis D therapy | ||
| 25.05. | Late-breakers to look out for at ASCO 2026 | ||
| 25.05. | Oral Wegovy backed by CHMP at May meeting | ||
| 22.05. | GBL joins CVC in €10.7bn takeover bid for Recordati |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.